Palbociclib = Ibrance = Pfizer

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Payzone

Rank: Mail Room [?]

Points: 198 [?]

Votes: 6 Score: 4.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Palbociclib = Ibrance = Pfizer

posted on May 19, 2020 10:44AM

I think the abstract is the setup for the next clinical trial and it includes another Pfizer compound.

Pfizer - Palbociclib - Ibrance

Eli Lilly - Abemaciclib - Verzenio/Verzenios

More Pfizer compounds mentioned in previous posts where ZEN-3694 has synergies.

Palbociclib - ER+ Breast cancer (4th trial listed on slide 6 of the AGM deck, with Pfizer again?)
Sunitinib - NSCLC (non small cell lung cancer)
Crizotinib - AML (acute myeloid leukemia)
Vidaza - Melanoma

6 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply